Total Payments
$10,960
2024 Payments
$1,334
Companies
58
Transactions
517
Medicare Patients
4,656
Medicare Billing
$632,284
Payment Breakdown by Category
Food & Beverage$9,053 (82.6%)
Travel$1,843 (16.8%)
Other$63.00 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,053 | 507 | 82.6% |
| Travel and Lodging | $1,843 | 9 | 16.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $63.00 | 1 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Nevro Corp. | $2,178 | 73 | $0 (2024) |
| Vertiflex, Inc. | $1,472 | 15 | $0 (2019) |
| Medtronic USA, Inc. | $966.46 | 19 | $0 (2020) |
| Collegium Pharmaceutical, Inc. | $581.12 | 32 | $0 (2024) |
| Boston Scientific Corporation | $556.56 | 13 | $0 (2024) |
| Daiichi Sankyo Inc. | $440.88 | 42 | $0 (2018) |
| PFIZER INC. | $394.92 | 37 | $0 (2021) |
| Abbott Laboratories | $378.00 | 21 | $0 (2023) |
| Scilex Pharmaceuticals Inc. | $287.88 | 17 | $0 (2023) |
| MicroVention, Inc. | $249.38 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,334 | 49 | Boston Scientific Corporation ($370.23) |
| 2023 | $1,063 | 54 | Nevro Corp. ($224.96) |
| 2022 | $830.39 | 28 | Nevro Corp. ($496.42) |
| 2021 | $575.74 | 34 | Nevro Corp. ($154.92) |
| 2020 | $512.20 | 32 | Nevro Corp. ($136.09) |
| 2019 | $2,655 | 66 | Vertiflex, Inc. ($1,472) |
| 2018 | $2,415 | 128 | Medtronic USA, Inc. ($828.52) |
| 2017 | $1,573 | 126 | Nevro Corp. ($331.61) |
All Payment Transactions
517 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: Gastroenterology | ||||||
| 12/10/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 11/19/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: PAIN MANAGEMENT | ||||||
| 11/14/2024 | Forte Bio-Pharma LLC | NALOCET (Drug), PROLATE, PROLATE | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: PAIN | ||||||
| 11/11/2024 | Boston Scientific Corporation | Superion Indirect Decompression System (Device) | Food and Beverage | In-kind items and services | $147.18 | General |
| Category: Vertiflex Superion_NMD | ||||||
| 11/07/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $26.27 | General |
| Category: Spinal Cord Stimulator | ||||||
| 10/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $22.04 | General |
| Category: Gastroenterology | ||||||
| 10/07/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $29.09 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 10/03/2024 | DePuy Synthes Sales Inc. | MONOVISC (Device) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: Sports Early Intervention | ||||||
| 10/02/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $21.51 | General |
| Category: Opioid Analgesic | ||||||
| 09/26/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $140.25 | General |
| Category: Spinal Cord Stimulator | ||||||
| 09/26/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $22.09 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 09/25/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $21.21 | General |
| Category: NEUROSCIENCE | ||||||
| 09/18/2024 | SI-BONE, INC. | — | Food and Beverage | Cash or cash equivalent | $27.94 | General |
| 09/14/2024 | Saluda Medical Americas, Inc. | Evoke (Device) | Food and Beverage | In-kind items and services | $12.85 | General |
| Category: Spinal Cord Stimulator | ||||||
| 09/14/2024 | Saluda Medical Americas, Inc. | Evoke (Device) | Food and Beverage | In-kind items and services | $10.75 | General |
| Category: Spinal Cord Stimulator | ||||||
| 09/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: Gastroenterology | ||||||
| 08/27/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: PAIN MANAGEMENT | ||||||
| 08/20/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $8.00 | General |
| Category: Spinal Cord Stimulator | ||||||
| 08/16/2024 | Saluda Medical Americas, Inc. | Evoke (Device) | Food and Beverage | In-kind items and services | $5.92 | General |
| Category: Spinal Cord Stimulator | ||||||
| 08/08/2024 | Forte Bio-Pharma LLC | NALOCET (Drug), PROLATE, PROLATE | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: PAIN | ||||||
| 08/06/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $25.05 | General |
| Category: PAIN MANAGEMENT | ||||||
| 07/24/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $19.74 | General |
| Category: Opioid Analgesic | ||||||
| 07/19/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: Spinal Cord Stimulator | ||||||
| 06/25/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $15.12 | General |
| Category: Opioid Analgesic | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,402 | 6,573 | $593,510 | $151,880 |
| 2022 | 25 | 1,476 | 6,021 | $707,142 | $199,056 |
| 2021 | 19 | 930 | 4,188 | $505,325 | $157,421 |
| 2020 | 18 | 848 | 3,873 | $443,778 | $123,928 |
Total Patients
4,656
Total Services
20,655
Medicare Billing
$632,284
Procedure Codes
85
All Medicare Procedures & Services
85 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 187 | 485 | $82,450 | $30,690 | 37.2% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2023 | 93 | 121 | $89,345 | $23,188 | 26.0% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2023 | 59 | 99 | $59,400 | $17,534 | 29.5% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Office | 2023 | 61 | 79 | $47,400 | $14,540 | 30.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 126 | 126 | $50,001 | $14,442 | 28.9% |
| 98977 | Device supply with scheduled recording and transmission for remote monitoring of musculoskeletal system, per 30 days | Office | 2023 | 60 | 206 | $25,132 | $6,833 | 27.2% |
| 98980 | Remote therapeutic monitoring treatment management services by physician or other qualified health care professional, first 20 minutes per calendar month | Office | 2023 | 56 | 184 | $21,344 | $6,384 | 29.9% |
| 63650 | Insertion of spinal neurostimulator electrode array through skin | Facility | 2023 | 15 | 24 | $88,800 | $6,284 | 7.1% |
| 98981 | Remote therapeutic monitoring treatment management services by physician or other qualified health care professional, each additional 20 minutes per calendar month | Office | 2023 | 51 | 173 | $16,435 | $4,981 | 30.3% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2023 | 22 | 30 | $18,800 | $4,678 | 24.9% |
| 64490 | Injection of upper or middle spine facet joint using imaging guidance, single level | Office | 2023 | 21 | 27 | $18,000 | $4,616 | 25.6% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2023 | 28 | 35 | $19,280 | $4,250 | 22.0% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Office | 2023 | 35 | 46 | $10,810 | $3,737 | 34.6% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2023 | 20 | 32 | $10,560 | $2,651 | 25.1% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2023 | 18 | 26 | $8,200 | $2,223 | 27.1% |
| 64491 | Injection of upper or middle spine facet joint using imaging guidance, second level | Office | 2023 | 19 | 24 | $7,875 | $2,077 | 26.4% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Office | 2023 | 31 | 41 | $4,920 | $1,429 | 29.0% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 11 | 12 | $2,175 | $558.59 | 25.7% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 251 | 4,110 | $5,135 | $397.19 | 7.7% |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | Office | 2023 | 222 | 676 | $5,408 | $236.35 | 4.4% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 16 | 17 | $2,040 | $150.08 | 7.4% |
| 63650 | Insertion of spinal neurostimulator electrode array through skin | Office | 2022 | 18 | 28 | $103,600 | $39,088 | 37.7% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2022 | 92 | 139 | $96,300 | $28,117 | 29.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 206 | 459 | $78,030 | $25,289 | 32.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 183 | 183 | $73,200 | $21,903 | 29.9% |
About Dr. Adam Wallace, M.D
Dr. Adam Wallace, M.D is a Pain Medicine healthcare provider based in Tulsa, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/29/2008. The National Provider Identifier (NPI) number assigned to this provider is 1518129733.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Adam Wallace, M.D has received a total of $10,960 in payments from pharmaceutical and medical device companies, with $1,334 received in 2024. These payments were reported across 517 transactions from 58 companies. The most common payment nature is "Food and Beverage" ($9,053).
As a Medicare-enrolled provider, Wallace has provided services to 4,656 Medicare beneficiaries, totaling 20,655 services with total Medicare billing of $632,284. Data is available for 4 years (2020–2023), covering 85 distinct procedure/service records.
Ad
Practice Information
- Specialty Pain Medicine
- Location Tulsa, OK
- Active Since 06/29/2008
- Last Updated 04/29/2019
- Taxonomy Code 207LP2900X
- Entity Type Individual
- NPI Number 1518129733
Products in Payments
- Superion ISS (Device) $1,472
- Senza Spinal Cord Stimulation System (Device) $990.03
- OSTEOCOOL RF ABLATION (Device) $805.01
- Omnia (Device) $651.34
- Senza (Device) $536.30
- Belbuca (Drug) $392.02
- LYRICA (Drug) $330.17
- RELISTOR ORAL (Drug) $280.56
- Horizant (Drug) $256.77
- Superion Indirect Decompression System (Device) $251.59
- LVIS (Device) $249.38
- Nucynta (Drug) $236.05
- Movantik (Drug) $228.42
- Morphabond ER (Drug) $212.46
- ZTLido (Drug) $197.18
- QUTENZA (Drug) $174.51
- INTELLIS ADAPTIVESTIM (Device) $171.09
- HYSINGLA ER (Drug) $156.46
- OXTELLAR XR (Drug) $149.83
- BOTOX (Biological) $148.10
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pain Medicine Doctors in Tulsa
Dr. Daniel Morris, Do, DO
Pain Medicine — Payments: $71,391
Pain Medicine $71,391
Dr. Traci White, M.d, M.D
Pain Medicine — Payments: $20,568
Pain Medicine $20,568
Brian Torgerson, M.d, M.D
Pain Medicine — Payments: $15,230
Pain Medicine $15,230
Dr. Lam Nguyen, Do, DO
Pain Medicine — Payments: $15,197
Pain Medicine $15,197
Dr. Jayen Patel, Md, MD
Pain Medicine — Payments: $14,399
Pain Medicine $14,399
Kenneth Reed, Md, MD
Pain Medicine — Payments: $10,938
Pain Medicine $10,938